Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.
Where
Shanghai
Age
18 years and over
People
246
Run by
Sinocelltech Ltd.
See details and how to joinNCT07362459
Phase 1/2Taking people
A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib
Where
Beijing, Changsha, Jinan, Xiamen, Zhengzhou
Age
18 years to 75 years
People
110
Run by
Henan Genuine Biotech Co., Ltd.
See details and how to joinNCT07362940
No phaseTaking people
Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
Where
Shanghai
Age
18 years and over
People
90
Run by
Ruijin Hospital
See details and how to joinNCT07232433
Phase 2Not yet taking people in China
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD
Where
Beijing
Age
18 years to 80 years
People
44
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07357532
Phase 4Not yet taking people in China
Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients
Where
Shanghai, Xuzhou
Age
18 years and over
People
40
Run by
Fudan University
See details and how to joinNCT07358520
Phase 3Not yet taking people in China
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
480
Run by
Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT07360132
Phase 1Taking people
A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations
Where
Shanghai
Age
18 years to 75 years
People
36
Run by
Tongji University
See details and how to joinNCT07361237
Phase 3Taking people
A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations
Where
Shanghai
Age
18 years to 75 years
People
300
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06430437
Phase 1Taking people
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors
Where
Shanghai
Age
18 years and over
People
20
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06612840
Phase 1/2Taking people
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
Where
Beijing
Age
18 years and over
People
170
Run by
3H Pharmaceuticals Co., Ltd.
See details and how to joinNCT07354711
No phaseTaking people
68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
Where
Beijing
Age
18 years to 80 years
People
10
Run by
Peking University First Hospital
See details and how to joinNCT07331532
No phaseNot yet taking people in China
Study on the Effectiveness and Safety of CLE Combined With Cryobiopsy for Diagnosis of Pulmonary Lesions
Where
Guangzhou
Age
18 years and over
People
40
Run by
Guangzhou Medical University
See details and how to joinNCT07352176
No phaseNot yet taking people in China
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk
Where
Ningbo
Age
18 years to 80 years
People
1,400
Run by
First Affiliated Hospital of Ningbo University
See details and how to joinNCT07347977
Phase 2Not yet taking people in China
Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
Where
Hangzhou
Age
18 years to 75 years
People
45
Run by
Zhejiang Cancer Hospital
See details and how to joinNCT07343479
Phase 2Taking people
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
Where
Guangzhou
Age
18 years to 75 years
People
56
Run by
Sun Yat-sen University
See details and how to joinNCT07103395
No phaseNot yet taking people in China
A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients
Where
Beijing, Chengdu, Guangzhou, Shanghai, Weihui
Age
18 years and over
People
3,000
Run by
Guangzhou University of Traditional Chinese Medicine
See details and how to joinNCT07338396
Phase 1Taking people
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Where
Hangzhou, Shanghai, Wuhan, Zhengzhou
Age
18 years and over
People
200 worldwide
Run by
Phrontline Biopharma
See details and how to joinNCT07181473
Phase 2Not yet taking people in China
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
Where
Jinan
Age
18 years and over
People
90
Run by
Li Min
See details and how to joinNCT07333651
Phase 1/2Taking people
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Where
Beijing, Changchun, Jinan
Age
18 years and over
People
102 worldwide
Run by
Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT05490472
No phaseTaking people
Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years to 80 years
People
250
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07328945
Phase 2Taking people
TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy
Where
Tianjin
Age
17 years to 75 years
People
41
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07330037
Phase 2Taking people
WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
Where
Tianjin
Age
18 years to 75 years
People
31
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07330050
Phase 2Taking people
QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC
Where
Hefei
Age
18 years to 75 years
People
96
Run by
Anhui Provincial Cancer Hospital
See details and how to joinNCT07330596
Phase 2Taking people
Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification
Where
Qingdao
Age
18 years to 80 years
People
60
Run by
Qingdao Central Hospital
See details and how to joinNCT07322783
Phase 2Taking people
Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years and over
People
36
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07323056